D.S

Hoag Family Cancer Institute Welcomes Oncology 'Power Couple'

Retrieved on: 
Donnerstag, April 25, 2024
Cloud, Circle, Cancer, University, D.S, Hospital, Drug development, Hematology, Immunotherapy, Oncology, Research, Pathology, University of Texas System, Cedars-Sinai Medical Center, Patient, Medicine, Lung, Breast cancer, Nursing

NEWPORT BEACH, Calif., April 25, 2024 /PRNewswire/ -- Hoag is proud to announce the recruitment of cancer researchers and subspecialized oncologists Monica Mita, M.D., M.Sc., Mh.D.S., and Alain Mita, M.D., M.Sc., to the Hoag Family Cancer Institute.

Key Points: 
  • Husband and wife team Alain Mita, M.D., and Monica Mita, M.D., join Hoag from Cedars-Sinai Medical Center as new program directors
    NEWPORT BEACH, Calif., April 25, 2024 /PRNewswire/ -- Hoag is proud to announce the recruitment of cancer researchers and subspecialized oncologists Monica Mita, M.D., M.Sc., Mh.D.S., and Alain Mita, M.D., M.Sc., to the Hoag Family Cancer Institute.
  • Dr. Monica Mita joins Hoag as co-director of early phase development therapy and co-director of breast medical oncology.
  • These advanced treatments offered at the Hoag Family Cancer Institute are usually only available at large academic cancer centers, which makes Hoag so unique."
  • He also completed an advanced oncology drug development fellowship program at the Institute for Drug Development at the Cancer Therapy and Research Center and University of Texas Health Science Center.

RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)

Retrieved on: 
Dienstag, Dezember 5, 2023
Health, Communications, Clinical Trials, Pharmaceutical, Publishing, Optical, Biotechnology, Yoshi, Intravitreal injection, Safety, Visual acuity, Retina, Royal college, Anatomy, Risk, Exudate, Anti-VEGF, FGF2, Patient, P, Choroidal neovascularization, Aptamer, Eye, Therapy, Blood, Growth factor, Royal College of Ophthalmologists, Paratriathlon, NAMD, SUSHI, Fibrosis, Pharmaceutical industry, D.S

TEMPURA is an investigator-sponsored, single-center, open-label, 4-month study of umedaptanib pegol in five treatment-naïve nAMD patients.

Key Points: 
  • TEMPURA is an investigator-sponsored, single-center, open-label, 4-month study of umedaptanib pegol in five treatment-naïve nAMD patients.
  • Throughout these studies umedaptanib pegol was safe, well tolerated, and effective to treat nAMD patients with no or short history of anti-VEGF treatment.
  • In nAMD patients with a long history of anti-VEGF treatment, umedaptanib pegol showed no additional benefit of monotherapy or the combination over Eylea®.
  • Notably, visual acuity decreased slightly in patients who switched from anti-VEGF (Eylea®) to umedaptanib pegol in the RAMEN study.

KnowBe4 Analysis Finds Security Awareness Training and Simulated Phishing Effective in Reducing Cybersecurity Risk

Retrieved on: 
Montag, Oktober 30, 2023
Mobile, Wireless, Technology, Security, Software, Networks, Internet, Training, Data Management, Education, Artificial Intelligence, Information security operations center, PST, SR, Risk, Simulated phishing, Security awareness, Cryptocurrency, Security printing, Risk management, D.S

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced it has released a new analysis of the effectiveness of security awareness training and simulated phishing on reducing cybersecurity risk, based on data from over 60,000 individual KnowBe4 customer organizations worldwide.

Key Points: 
  • KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced it has released a new analysis of the effectiveness of security awareness training and simulated phishing on reducing cybersecurity risk, based on data from over 60,000 individual KnowBe4 customer organizations worldwide.
  • The new KnowBe4 white paper, “ Data Confirms Value of Security Awareness Training and Simulated Phishing ”, is based on the largest analysis of its kind, with over 32 million individual end users, who took over 493 million Phishing Security Tests (PSTs) and participated in awareness training at least once a year.
  • Groups that did weekly PSTs were 2.74 times more effective in reducing risk than groups that only did less than quarterly PSTs.
  • “Based on the massive amount of data that we analyzed from around the world, everyone should be conducting frequent simulated phishing tests as part of their security awareness training program to get the highest level of impact and most effective cybersecurity risk reduction,” said Roger Grimes, data-driven defense evangelist, KnowBe4.

IDE Technologies Secures Contract with CleanEdge Water to Design, Build New Wastewater Treatment Plant in India

Retrieved on: 
Dienstag, Juli 25, 2023
Energy, Natural Resources, Utilities, Other Natural Resources, Business development, WWTP, IX, Regeneration, IDE Technologies, Water, BOOT, IDE, C&I, D.S, Sewage treatment, Lithium

IDE Technologies , a leading global provider of water treatment solutions, is pleased to announce that CleanEdge Water Pte Ltd. awarded IDE a contract to deliver a state-of-the-art wastewater treatment plant (WWTP) for a mining industry application in India.

Key Points: 
  • IDE Technologies , a leading global provider of water treatment solutions, is pleased to announce that CleanEdge Water Pte Ltd. awarded IDE a contract to deliver a state-of-the-art wastewater treatment plant (WWTP) for a mining industry application in India.
  • CleanEdge Water is a Singapore-based integrated industrial wastewater solutions provider for C&I clients in South East Asia and India on BOOT basis.
  • “We are thrilled to continue our tremendous momentum in bringing innovative wastewater treatment plants to regions in need of clean, potable water,” said Dr. Efrat Miller, VP and Head of the Water Treatment Department and Business Development, IDE.
  • For more information on IDE’s large scale projects and advanced, proprietary water treatment solutions, visit www.ide-tech.com .

Responsible Mining Solutions and Atico Mining Corp. Complete Commissioning and Ramp-Up of the El Roble Mine’s Integrated Tailings Dewatering Facility

Retrieved on: 
Donnerstag, Januar 13, 2022
Plata, International Council on Mining and Metals, ITDS, Export Development Canada, International Council, Copper, RMS, Happiness, Trade Commissioner Service, COVID-19, Kabul attack on Canadian Embassy guards, Public expenditure, ATY, Diplomatic mission, D.S, Investor, Gold, GLOBE, Health, Industry, Company, Association, Water, Environment, Filter cake, Metallurgy, Institute, Acquisition, Oil, Mining, Mining

VANCOUVER, British Columbia, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Responsible Mining Solutions Corp. (RMS) and Atico Mining Corporation (the Company or Atico) (TSX.V: ATY | OTCQX: ATCMF) RMS and Atico jointly announce that they have successfully completed the commissioning and hand-over of the Integrated Tailings Dewatering Plant (ITDS) designed to receive flotation tailings from the El Roble mill and processing facilities.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Responsible Mining Solutions Corp. (RMS) and Atico Mining Corporation (the Company or Atico) (TSX.V: ATY | OTCQX: ATCMF) RMS and Atico jointly announce that they have successfully completed the commissioning and hand-over of the Integrated Tailings Dewatering Plant (ITDS) designed to receive flotation tailings from the El Roble mill and processing facilities.
  • This project was successfully delivered amidst the COVID-19 pandemic and constitutes 3-years of conceptual, feasibility engineering and extensive testwork campaigns.
  • of copper flotation tailings materials, increasing the density from 60-65% w/w solids to 88% w/w solids.
  • Atico is a growth-oriented Company, focused on exploring, developing and mining copper and gold projects in Latin America.